Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and
Julie B Mortensen1, Ida Monrad1, Marie B Enemark1
1Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Background:
The programmed cell death protein 1 (PD-1) and its ligand 1 and 2 (PD-L1/PD-L2) regulate the immune system, and the checkpoint pathway can be exploited by malignant cells to evade anti-tumor immune response. Soluble forms (sPD-1/sPD-L1/sPD-L2) exist in the peripheral blood, but their biological and clinical significance is unclear.
Method:
Time-resolved immunofluorometric assay (TRIFMA) and enzyme-linked immunosorbent assay (ELISA) were used to measure sPD-1, sPD-L1, and sPD-L2 levels in serum from 131 lymphoma patients and 22 healthy individuals.
Results:
Patients had higher sPD-1 and sPD-L2 levels than healthy individuals. In diffuse large B-cell lymphoma, patients with high International Prognostic Index score had higher sPD-1 levels and sPD-L2 levels correlated with subtype according to cell of origin. Compared to other lymphoma types, follicular lymphoma displayed higher sPD-1 and lower sPD-L1 levels along with lower ligand/receptor ratios.
Conclusion:
This is the first study to simultaneously characterize pretherapeutic sPD-1, sPD-L1, and sPD-L2 in a variety of lymphoma subtypes. The relation between higher sPD-1 levels and adverse prognostic factors suggests a possible biological role and potential clinical usefulness of sPD-1. Moreover, the reverse expression pattern in follicular lymphoma and T-cell lymphoma/leukemia may reflect biological information relevant for immunotherapy targeting the PD-1 pathway.
Insights
Soluble programmed cell death protein 1 (sPD-1) and soluble PD-L2 levels are elevated in lymphoma patients. Higher sPD-1 correlates with adverse prognostic factors, suggesting potential clinical utility in immunotherapy targeting the PD-1 pathway.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- The programmed cell death protein 1 (PD-1) pathway is crucial for immune regulation and is often exploited by cancers to evade immune responses.
- Soluble forms of PD-1 (sPD-1) and its ligands (sPD-L1/sPD-L2) are present in blood, but their clinical significance in lymphoma remains largely unknown.
Purpose of the Study:
- To investigate the biological and clinical significance of soluble PD-1, PD-L1, and PD-L2 (sPD-1, sPD-L1, sPD-L2) in various lymphoma subtypes.
- To explore the association of these soluble immune checkpoint molecules with prognostic factors and lymphoma characteristics.
Main Methods:
- Serum samples from 131 lymphoma patients and 22 healthy individuals were analyzed.
- Time-resolved immunofluorometric assay (TRIFMA) and enzyme-linked immunosorbent assay (ELISA) were employed to quantify sPD-1, sPD-L1, and sPD-L2 levels.
Main Results:
- Lymphoma patients exhibited significantly higher serum levels of sPD-1 and sPD-L2 compared to healthy controls.
- Elevated sPD-1 levels were associated with higher International Prognostic Index scores in diffuse large B-cell lymphoma.
- Follicular lymphoma showed distinct patterns of higher sPD-1 and lower sPD-L1 levels, along with reduced ligand/receptor ratios, compared to other lymphoma types.
Conclusions:
- This study provides the first comprehensive characterization of pretherapeutic sPD-1, sPD-L1, and sPD-L2 across diverse lymphoma subtypes.
- The correlation of higher sPD-1 with adverse prognostic factors suggests a potential role in disease progression and clinical utility for immunotherapy.
- Differential expression patterns, particularly in follicular lymphoma, may offer valuable biological insights for PD-1 pathway-targeted immunotherapies.
More Related Videos
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Regulation of Hematopoietic Stem Cells
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
